Literature DB >> 571113

Stimulation of phrenic nerve activity by an acetylcholine releasing drug: 4-aminopyridine.

H Folgering, J Rutten, S Agoston.   

Abstract

The effect of the acetylcholine releaser 4-aminopyridine on ventilation was studied by recording and quantifying the efferent phrenic nerve activity in 40 paralysed and vagotomized cats; with arterial Po2, PCO2 and pH kept constant. 4-Aminopyridine, given intravenously or in the vertebral artery, stimulates the phrenic nerve activity in a dose dependent manner. The stimulatory effects of 4-aminopyridine on the phrenic nerve activity could be abolished completely by administration of high doses of atropine. We conclude that 4-aminopyridine, which is used clinically for the reversal of a neuromuscular block, stimulates the phrenic nerve activity. Since the role of cholinergic mechanisms in the central chemoreception has been well established, the effect on the phrenic nerve activity is most probably by an increased release of acetylcholine at the site of the central chemoreceptors.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 571113     DOI: 10.1007/bf00586945

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  12 in total

1.  MICRO-METHOD FOR THE ESTIMATION OF CALCIUM BY AUTO ANALYSER.

Authors:  M R WILLS; B C GRAY
Journal:  J Clin Pathol       Date:  1964-11       Impact factor: 3.411

2.  Clinical electromyomechanographic and electromyographic studies in decurarization with pymadine.

Authors:  E Stoyanov; P Vulchev; M Shturbova; M Marinova
Journal:  Anaesth Resusc Intensive Ther       Date:  1976 Apr-Jun

3.  Calcium decrease associated with aminopyridine-induced potassium increase in cat cerebellum.

Authors:  C Nicholson; R Steinberg; H Stöckle; G T Bruggencate
Journal:  Neurosci Lett       Date:  1976-12       Impact factor: 3.046

4.  Effects of 4-aminopyridine on neuromuscular transmission.

Authors:  H Lundh
Journal:  Brain Res       Date:  1978-09-22       Impact factor: 3.252

5.  Analysis of the effects of 4-amino pyridine on the lumbar cord of the cat. II. Modifications of certain spinal inhibitory phenomena, post-tetanic potentiation and dorsal root potentials.

Authors:  M Lemeignan
Journal:  Neuropharmacology       Date:  1973-07       Impact factor: 5.250

6.  Analysis of the action of 4-amino pyridine on the cat lumbar spinal cord. I. Modification of the afferent volley, the monosynaptic discharge amplitude and the polysynaptic evoked responses.

Authors:  M Lemeignan
Journal:  Neuropharmacology       Date:  1972-07       Impact factor: 5.250

7.  Ventilation estimated from efferent phrenic nerve activity in the paralysed cat.

Authors:  F D Smolders; H T Folgering; J A Bernards
Journal:  Pflugers Arch       Date:  1975-08-29       Impact factor: 3.657

8.  Influence of CSF calcium concentration on the ventilatory response to CO2 and O2.

Authors:  A Berkenbosch; A J Adan
Journal:  Pflugers Arch       Date:  1974-04-04       Impact factor: 3.657

9.  Capnostat and oxystat. Electronic devices to automatically maintain the end-tidal PCO2 and PO2 of a subject connected to a closed respiratory circuit at adjustable levels.

Authors:  F D Smolders; H T Folgering; J A Bernards
Journal:  Pflugers Arch       Date:  1977       Impact factor: 3.657

10.  Synaptic transmission in the sixth ganglion of the cockroach: action of 4-aminopyridine.

Authors:  B Hue; M Pelhate; J J Callec; J Chanelet
Journal:  J Exp Biol       Date:  1976-12       Impact factor: 3.312

View more
  3 in total

1.  Cholinergic modulation of memory in rats.

Authors:  V Haroutunian; E Barnes; K L Davis
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

2.  4-Aminopyridine antagonizes the inhibitory effect of pentobarbital on acetylcholine release in the heart.

Authors:  W Weide; K Löffelholz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-05       Impact factor: 3.000

3.  Effective treatment of verapamil intoxication with 4-aminopyridine in the cat.

Authors:  S Agoston; E Maestrone; E J van Hezik; J M Ket; M C Houwertjes; D R Uges
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.